- Polyarticular (both rheumatoid factor positive and rheumatoid factor
negative),oligoarticular and extended oligoarticular JIA for ≥3 months meeting the
International League of Associations for Rheumatology (ILAR) criteria for Juvenile
Idiopathic Arthritis (JIA)
- Subjects with Systemic JIA with active arthritis in at least 1 joint but without
active systemic features are eligible
- ≥2 years of age and
- Body weight ≥10 kg at the Baseline visit
- Candidate for chronic NSAID therapy in the Investigator's judgment
- Psoriatic arthritis, enthesitis-related arthritis, and undifferentiated arthritis
types of JIA
- Active systemic features over the prior 12 weeks in children with systemic Juvenile
Idiopathic Arthritis (JIA)
- Subjects with psoriatic arthritis, enthesitis-related arthritis, and undifferentiated
arthritis should be excluded
- Subjects with active Systemic JIA should not be enrolled